Showing results (51-60 of 628) with videos related to
Sort By:
Pageof 63
Current Molecular Medicine|August 14, 2020
Obesity and Insulin Resistance: A Review of Molecular InteractionsHabib Yaribeygi, Mina Maleki, Thozhukat Sathyapalan, et al.Journal of Diabetes Research|March 28, 2020
Molecular Mechanisms by Which Imeglimin Improves Glucose HomeostasisHabib Yaribeygi, Mina Maleki, Thozhukat Sathyapalan, et al.Life Sciences|June 14, 2020
Incretin-based therapies and renin-angiotensin system: Looking for new therapeutic potentials in the diabetic milieuHabib Yaribeygi, Mina Maleki, Thozhukat Sathyapalan, et al.Advances in Experimental Medicine and Biology|January 4, 2022
Naturally Occurring SGLT2 Inhibitors: A ReviewHabib Yaribeygi, Milad Ashrafizadeh, Thozhukat Sathyapalan, et al.Chinese Journal of Integrative Medicine|October 24, 2025
Effect and Safety of Phytosomal Curcumin Supplementation on Migraine Patients: A Randomized, Double-Blind and Placebo-Controlled TrialMehrnaz Shojaei, Fariborz Khorvash, Amirhossein Sahebkar, et al.Advances in Experimental Medicine and Biology|July 31, 2021
The Effect of Curcumin Supplemsentation on Anthropometric Indices in Overweight and Obese Individuals: A Systematic Review of Randomized Controlled TrialsZahra Safari, Mohammad Bagherniya, Gholamreza Askari, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 12, 2022
Identification of difluorinated curcumin molecular targets linked to traumatic brain injury pathophysiologyAmirhossein Sahebkar, Thozhukat Sathyapalan, Paul C Guest, et al.Current Medicinal Chemistry|April 18, 2022
The Effect of Probiotic and Synbiotic Consumption on the Most Prevalent Chemotherapy-related Complications: A Systematic Review of Current LiteratureArman Arab, Elham Karimi, Mohammad Bagherniya, et al.Current Medicinal Chemistry|February 3, 2023
Cognitive Benefits of Sodium-Glucose Co-Transporters-2 Inhibitors in the Diabetic MilieuHabib Yaribeygi, Mina Maleki, Thozhukat Sathyapalan, et al.Biomedicines|June 27, 2024
Effect of Hypoglycemia and Rebound Hyperglycemia on Proteomic Cardiovascular Risk BiomarkersManjula Nandakumar, Thozhukat Sathyapalan, Stephen L Atkin, et al.Pageof 63